UK markets open in 4 hours 42 minutes

Sinopharm Group Co. Ltd. (X2S.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.5510-0.0010 (-0.04%)
At close: 08:05AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
8,765,042
8,525,655
7,758,646
7,187,278
Depreciation & amortisation
3,373,216
4,165,019
3,922,058
3,597,114
Stock-based compensation
-19,739
-
0
-18,569
Change in working capital
-13,215,963
-2,073,701
-12,101,333
-8,719,963
Inventory
-4,957,594
-9,504,224
-4,345,332
-3,675,404
Other working capital
10,424,845
18,546,258
7,052,443
9,067,285
Other non-cash items
2,711,698
3,339,594
3,570,129
3,245,004
Net cash provided by operating activities
-
20,963,787
9,308,085
11,154,609
Cash flows from investing activities
Investments in property, plant and equipment
-2,436,231
-2,417,529
-2,255,642
-2,087,324
Acquisitions, net
-1,399,924
-453,967
-506,858
-2,707,692
Purchases of investments
-307,938
-100,000
-75,000
-248,300
Sales/maturities of investments
-140,393
211,530
298,627
23,654
Other investing activities
-833,527
-1,764,114
559,743
1,787,347
Net cash used for investing activities
-2,561,788
-3,589,622
-1,266,962
-2,202,758
Net change in cash
4,419,487
11,680,684
-6,651,884
10,977,705
Cash at beginning of period
28,829,191
43,529,428
50,178,265
39,191,967
Cash at end of period
33,267,595
55,221,624
43,529,428
50,178,265
Free cash flow
Operating cash flow
-
20,963,787
9,308,085
11,154,609
Capital expenditure
-2,436,231
-2,417,529
-2,255,642
-2,087,324
Free cash flow
10,424,845
18,546,258
7,052,443
9,067,285